Autosomal dominant optic atrophy (ADOA), generally caused by pathogenic variants in the OPA1 gene, is a hereditary optic neuropathy characterized by progressive degeneration of the optic nerve. Impaired mitochondrial function in retinal ganglion cells leads to bilateral visual loss, usually irreversible.
Autosomal dominant optic atrophy (OPA1 gene)
Autosomal dominant optic atrophy is one of the most frequent hereditary optic neuropathies and is mainly due to variants in the OPA1 gene. This gene encodes a mitochondrial protein involved in inner membrane fusion, mitochondrial cristae maintenance, and protection against cell death. Retinal ganglion cells, whose axons form the optic nerve, have a high energy demand and are particularly sensitive to mitochondrial dysfunction.
When OPA1 does not function correctly, mitochondrial organization is altered, and the vulnerability of these cells increases, causing bilateral optic nerve atrophy and loss of visual acuity. The estimated prevalence varies between populations; particularly high figures have been described in Denmark, due to founder effect, and in the northeast of England. The disease follows an autosomal dominant pattern with variable penetrance, meaning an affected person has a 50% chance of transmitting the variant to each child, although severity can vary even within the same family.
Symptoms
Classical ADOA typically begins in childhood, with bilateral, slowly progressive, and painless visual loss. Decreased visual acuity, central or cecocentral visual field defects, temporal optic disc pallor, and altered color perception are common. The severity is highly variable: some individuals retain functional vision for decades, while others may meet criteria for severe visual impairment. In a subgroup of patients, extraocular manifestations may appear, such as sensorineural hearing loss, ataxia, myopathy, or peripheral neuropathy.
Disease management
Management is based on regular ophthalmological controls, visual support, and functional adaptation through low vision aids, adequate lighting, magnification devices, and adapted educational or work resources. Genetic counseling is also recommended for affected families. As a preventive measure against progression, it is advised to avoid tobacco, excessive alcohol consumption, and medications with possible mitochondrial toxicity when alternatives exist.
Genes analyzed
Bibliography
Autosomal dominant optic atrophy, classic form orphanet [July 2020].
Wong DCS, Harvey JP, Jurkute N, et al. OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets. J Neuroophthalmol. 2023 Dec 1;43(4):464-474.
